Trials
Search / Trial NCT06437717

Role of Nanoemulsified Sesame Oil in Post-operative Care After Endoscopic Sinus Surgery

Launched by MANSOURA UNIVERSITY · May 25, 2024

Trial Information

Current as of February 08, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patient age between 18 and 60 years old.
  • 2. chronic rhinosinusitis patients who have undergone endoscopic sinus surgery.
  • Exclusion Criteria:
  • 1. Patients with history of allergy for sesame seed derivatives.
  • 2. Patients with chronic diseases which affecting the process of healing (uncontrolled DM, renal failure and hepatic failure).
  • 3. Patients with nasal granulomas.
  • 4. Patients with invasive fungal rhinosinusitis.
  • 5. Smokers.
  • 6. Patients with history of radio and/or chemotherapy exposure.
  • 7. Patients with systemic diseases affecting integrity of nasal mucosa (e.g. CF, scleroderma, Sjogren syndrome ...).

About Mansoura University

Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.

Locations

Mansoura, Dakahliya, Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0